Robert A. Winn

1 week ago | oncologynewscentral.com | Robert A. Winn |Robert A. Figlin

This transcript has been lightly edited for style and clarity. Robert A. Figlin, MD: Welcome, this is Bob Figlin, the Steven Spielberg Family Chair in Hematology-Oncology at Cedars-Sinai Cancer in Los Angeles. I’m delighted to visit with Bob Winn, who is the director and Lipman Chair in Oncology at VCU Massey Cancer Center and current president of the Association of American Cancer Institutes. Bob, thanks for joining us. Robert A. Winn, MD: Thank you for having me.

Apr 18, 2024 | cancernetwork.com | Robert A. Winn

In the ongoing fight against cancer, achieving equitable access toquality care is a critical challenge, according to Robert A. Winn, MD. Winn recently wrote a 2024 forecast focusing on achieving health equity in the oncology space for the American Association for Cancer Research (AACR). He spoke about the persistent disparities in cancer outcomes among different populations, and he emphasized the distinction between equity and disparity.

Mar 4, 2024 | cancernetwork.com | Robert A. Winn

In a conversation with CancerNetwork®, Robert A. Winn, MD, spoke about current obstacles in achieving equitable care for patients with cancer and discussed how initiatives from community health centers and federal bodies alike may help increase access to anti-cancer therapy.

Feb 22, 2024 | cancernetwork.com | Robert A. Winn

The American Association for Cancer Research (AACR) Health Disparities Report is a powerful tool that can help educate those in the oncology community on health equity issues among patients with cancer, according to Robert A. Winn, MD. Winn described his experiences with organizing the AACR Health Disparities Reports since the publication of the first in 2020. He stated that he was “happy” to be involved in this effort to help spread awareness of cancer disparities.

Feb 21, 2024 | cancernetwork.com | Robert A. Winn

Initiatives such as Medicaid paying for clinical trials and reimbursement policies from the Centers for Medicare & Medicaid Services may be “game changers” for moving towards health equity in oncology, according to Robert A. Winn, MD.